AMI Inc.
As of January 2024
City | Year of Establishment | Founder |
---|---|---|
Kumamoto | 2015 | Shimpei Ogawa |
Partner VC | Latest round of Fundraising | Valuation |
---|---|---|
Real Tech Holdings Co.,Ltd. | Series B | JPY 4,070 million |
- Contact Information : dev_secretary@ami.inc
- Website : AMI Inc.
Program name
Deep-Tech Startups Support Program
Research theme
Social Implementation of the Heart Sound AI Diagnostic Assistance System and Development of Heart Sound Biomarkers
Business Plan
The main focus is on developing a compact, low-noise, and high signal-to-noise ratio super stethoscope, capable of measuring heart sounds and electrocardiograms. By utilizing signal processing and deep learning technologies, we aim to develop and implement heart failure and heart valve disease estimating AI. Through the commercialization of heart sound analysis Doctor to Doctor service, we aim to screen these cardiac diseases and connect individuals to appropriate treatment in preparation for the upcoming heart failure pandemic.
Research Outline
In this research and development, we will enhance the accuracy of the severity classification AI for heart valve diseases, conduct clinical performance trials, and apply for regulatory approval. Additionally, we will develop two new AIs capable of identifying cardiac conditions, and expand the suite of diagnostic assistance functions. Furthermore, we will have end users utilize the remote auscultation heart sound analysis Doctor to Doctor service and conduct surveys to gather feedback. Using this feedback, we will make interface improvements and assess business viability, and aim for an official release.
Phase | Business Area/Field | Research Period | Research Grant Amount |
---|---|---|---|
PCA | Healthcare | 2023~2024 FY | JPY 183 million |
International collaborative technology demonstration
Countries/Regions | Collaborative activity outline |
---|---|
North America, Asia |
|
Last Updated : June 6, 2024